Apatinib is a novel inhibitor of VEGF receptor (VEGFR), which can block the vascular endothelial cell transduction pathway, thereby suppressing proliferation and migration of vascular endothelial cells, lowering tumor microvessel density, and preventing cancer progression13. This evidence concerns the gene KDR and neoplasm.